Robinson, David <br/><br/>
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Jun 2013 
 - f3406 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.f3406  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-alpha Reductase Inhibitors--therapeutic use<br/>Case-Control Studies<br/>Humans<br/>Lower Urinary Tract Symptoms--drug therapy<br/>Male<br/>Prostatic Neoplasms--epidemiology<br/>Risk Assessment<br/>Sweden